[PDF][PDF] Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient
Neth J Med, 2008•njmonline.nl
We describe a 34-year-old male patient suffering from familial Mediterranean fever and
experiencing an increase in both the frequency and severity of disease attacks, suggesting
resistance to chronic treatment with colchicine. since no alternative treatment is established,
anakinra, an interleukin-1 receptor antagonist, was administered, not daily, as it has been
previously reported, but only during crises, with successful outcome.
experiencing an increase in both the frequency and severity of disease attacks, suggesting
resistance to chronic treatment with colchicine. since no alternative treatment is established,
anakinra, an interleukin-1 receptor antagonist, was administered, not daily, as it has been
previously reported, but only during crises, with successful outcome.
Abstract
We describe a 34-year-old male patient suffering from familial Mediterranean fever and experiencing an increase in both the frequency and severity of disease attacks, suggesting resistance to chronic treatment with colchicine. since no alternative treatment is established, anakinra, an interleukin-1 receptor antagonist, was administered, not daily, as it has been previously reported, but only during crises, with successful outcome.
njmonline.nl